首页> 美国卫生研究院文献>ACS AuthorChoice >Shape-Controlled Paclitaxel Nanoparticles with MultipleMorphologies: Rod-Shaped Worm-Like Spherical and Fingerprint-Like
【2h】

Shape-Controlled Paclitaxel Nanoparticles with MultipleMorphologies: Rod-Shaped Worm-Like Spherical and Fingerprint-Like

机译:具有多个形状控制的紫杉醇纳米粒子形态:杆状蠕虫状球形和指纹状

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although many nanocarriers have been developed to encapsulate paclitaxel (PTX), the drug loading and circulation time in vivo always are not ideal because of its rigid “brickdust” molecular structure. People usually concentrate their attention on the spherical nanocarriers, here paclitaxel nanoparticles with different geometries were established through the chemical modification of PTX, nanoprecipitation, and core-matched cargos. Previously we have developed rod-shape paclitaxel nanocrystals using block copolymer, pluronic F127. Unfortunately, the pharmacokinetic (PK) profile of PTX nanocrystals is very poor. However, when PTX was replaced by its prodrug, the geometry of the nanoparticles changed from rod-shaped to worm-like. The worm-like nanoparticles can be further changed to spherical nanoparticles using the nanoprecipitation method, and changed to fingerprint-like nanoparticles upon the addition of the core-matched PTX. The nanoparticles with nonspherical morphologies, including worm-like nanoparticles and fingerprint-like nanoparticles, offer significant advantages in regards to key PK parameters in vivo. More important, in this report the application of the core-matching technology in creating a core-matched environmentcapable of controlling the in vivo PK of paclitaxelwas demonstrated, and it revealed a novel technique platform to constructnanoparticles and improve the poor PK profiles of the drugs.
机译:尽管已开发出许多纳米载体来封装紫杉醇(PTX),但由于其刚性的“砖屑”分子结构,体内药物的装载和循环时间始终不理想。人们通常将注意力集中在球形纳米载体上,在这里通过化学修饰PTX,纳米沉淀和核匹配的货物建立了具有不同几何形状的紫杉醇纳米颗粒。以前,我们使用嵌段共聚物pluronic F127开发了棒状紫杉醇纳米晶体。不幸的是,PTX纳米晶体的药代动力学(PK)曲线非常差。但是,当PTX被其前药替代时,纳米粒子的几何形状从杆状变为蠕虫状。蠕虫状纳米粒子可以使用纳米沉淀法进一步更改为球形纳米粒子,并在添加核心匹配的PTX后更改为指纹状纳米粒子。具有非球形形态的纳米颗粒,包括蠕虫状纳米颗粒和指纹状纳米颗粒,在体内关键PK参数方面具有明显优势。更重要的是,在本报告中,核心匹配技术在创建核心匹配环境中的应用能够控制紫杉醇的体内PK进行了演示,并揭示了一种新颖的技术平台纳米颗粒,改善了药物的不良PK曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号